SEC Form 4 · accession 0001013606-15-000105
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Steele Love
Officer — VP-Clinical Affairs
Period of report
May 28, 2015
Accepted (ET)
Jun 1, 2015 · 10:35 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 28, 2015 | A | 7,535 | $0.00 | A | 41,782 | D | |
| Common StockF2 | May 28, 2015 | A | 7,535 | $0.00 | A | 49,317 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF3 | $16.59 | May 28, 2015 | A | 18,854 | A | Jun 28, 2015 | May 28, 2025 | Common Shares | 18,854 | 18,854 | D |
Explanation of responses
- F1Time based restricted stock unit award.
- F2Performance restricted stock unit award based on a regulatory milestone.
- F3Options vest ratably over forty-eight months.